AI-generated analysis. Always verify with the original filing.
bioAffinity Technologies, Inc. issued a press release on March 10, 2026, announcing the initiation of an unspecified event, disclosed under Item 8.01 Other Events with Exhibit 99.1. This filing notifies investors of the press release issuance.
Event Type
Disclosure
Voluntary
Variant
8-K
. Other Events. On March 10, 2026, bioAffinity Technologies, Inc., a Delaware corporation (the “Company”), issued a press release announcing the initiation of i
. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press Release issued by bioAffinity Technologies, Inc., dated March 10, 2026